Helicobacter pylori pore-forming cytolysin orthologue TlyA possesses in vitro hemolytic activity and has a role in colonization of the gastric mucosa.
Hemolysins have been found to possess a variety of functions in bacteria, including a role in virulence. Helicobacter pylori demonstrates hemolytic activity when cultured on unlysed blood agar plates which is increased under iron-limiting conditions. However, the role of an H. pylori hemolysin in virulence is unclear. Scrutiny of the H. pylori 26695 genome sequence suggests the presence of at least two distinct hemolysins, HP1086 and HP1490, in this strain. Previous studies have shown that the in vitro hemolytic activity of H. pylori is reduced when it is coincubated with dextran 5000, suggesting the presence of a pore-forming cytolysin. HP1086 has homology to pore-forming cytolysins (TlyA) from other bacterial species, and the introduction of the cloned H. pylori tlyA gene into a nonhemolytic Escherichia coli strain conferred hemolytic activity. An H. pylori tlyA defined mutant showed reduced in vitro hemolytic activity, which appears to be due to pore formation, as the hemolytic activity of the wild-type strain is reduced to the same level as the tlyA mutant by the addition of dextran 5000. The mutant also showed reduced adhesion to human gastric adenocarcinoma cells and failed to colonize the gastric mucosa of mice. These data clearly suggest a role in virulence for H. pylori TlyA, contrary to the suggestion that hemolytic activity is an in vitro phenomenon for this pathogen.
Martino
M C
MC
Pathogen Molecular Biology and Biochemistry Unit, Department of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.
Stabler
R A
RA
Zhang
Z W
ZW
Farthing
M J
MJ
Wren
B W
BW
Dorrell
N
N
D000818:Animals; D001422:Bacterial Adhesion; D001426:Bacterial Proteins / Q000235:genetics / Q000633:toxicity*; D003603:Cytotoxins / Q000235:genetics / Q000633:toxicity*; D004926:Escherichia coli / Q000235:genetics; D005753:Gastric Mucosa / Q000382:microbiology*; D016481:Helicobacter Infections / Q000209:etiology; D016480:Helicobacter pylori / Q000235:genetics / Q000472:pathogenicity*; D006460:Hemolysin Proteins / Q000235:genetics / Q000633:toxicity*; D006801:Humans; D008297:Male; D051379:Mice; D009154:Mutation; D011994:Recombinant Proteins / Q000633:toxicity; D014407:Tumor Cells, Cultured; D037521:Virulence Factors / Q000235:genetics / Q000633:toxicity*
D001426:Bacterial Proteins; D003603:Cytotoxins; D006460:Hemolysin Proteins; D011994:Recombinant Proteins; C588092:TlyA protein, Helicobacter pylori; C112817:TlyA protein, Mycobacterium tuberculosis; D037521:Virulence Factors